Wada, H.; Ichikawa, Y.; Ezaki, M.; Yamamoto, A.; Tomida, M.; Yoshida, M.; Fukui, S.; Moritani, I.; Shiraki, K.; Shimaoka, M.;
et al. Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019. J. Clin. Med. 2022, 11, 985.
https://doi.org/10.3390/jcm11040985
AMA Style
Wada H, Ichikawa Y, Ezaki M, Yamamoto A, Tomida M, Yoshida M, Fukui S, Moritani I, Shiraki K, Shimaoka M,
et al. Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019. Journal of Clinical Medicine. 2022; 11(4):985.
https://doi.org/10.3390/jcm11040985
Chicago/Turabian Style
Wada, Hideo, Yuhuko Ichikawa, Minoru Ezaki, Akitaka Yamamoto, Masaki Tomida, Masamichi Yoshida, Shunsuke Fukui, Isao Moritani, Katsuya Shiraki, Motomu Shimaoka,
and et al. 2022. "Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019" Journal of Clinical Medicine 11, no. 4: 985.
https://doi.org/10.3390/jcm11040985
APA Style
Wada, H., Ichikawa, Y., Ezaki, M., Yamamoto, A., Tomida, M., Yoshida, M., Fukui, S., Moritani, I., Shiraki, K., Shimaoka, M., Iba, T., Suzuki-Inoue, K., & Shimpo, H.
(2022). Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019. Journal of Clinical Medicine, 11(4), 985.
https://doi.org/10.3390/jcm11040985
